new post
StocksRunner logo
mail
search
 
menu
 
Orchestra BioMed Hol
$5.35
+10.54%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

OBIO Stock Analysis & IQ Rating | Orchestra BioMed Holdings

 
 
 

OBIO

 

Orchestra BioMed Holdings

$5.35

 
+$0.51 | +10.54%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$6.3
 
 
MKT CAP
$302.09M
 
52W Low
$2.2
 
 
VOL
$645.40K
 
P/E Ratio
N/A
 
 
AVG VOL
$360.53K
 
RSI
73.16
 
 
TREND
Uptrend
 
 
 

OBIO Stock IQ

 
lock  Login to see Orchestra BioMed Holdings (OBIO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

OBIO Target Price

 
 
 

Strengths

 

OBIO Rewards

 Upgraded on attractively valued

OBIO Rewards

 Trading below its fair value

 
 

Chart

 
 

$3.79   (+41.16%)

$2.73   (+95.97%)

$2.89   (+85.12%)

$5.51   (-2.90%)

 
 
1year
6month
3month
1month
 

OBIO Risk Level

 

OBIO has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 Price under $5

 Low volume

 High volatilty

 
 
OBIO Risk Level
Medium
LOW
HIGH
 

OBIO Analysts Opinion

 

OBIO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

OBIO Earnings Sentiment

 Above analyst estimates

OBIO Earnings Sentiment

 Loss widens YoY

 
 

Rating

×
 

Rating

 

OBIO Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

OBIO Future Sentiment

 Trading below its fair value

 
 

OBIO Analysts Opinion

OBIO Analysts opinion is positive and also has improved from the past 3 months

 

OBIO Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
92%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

OBIO Street Sentiment 

OBIO Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

OBIO Performance Sentiment

 
Sentiments overview associated with OBIO events and the stock performance.
 
92%
8%
Positive
Negative
12 out of 13
events present
1 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$4.53
 
Resistance
Price
 
$2.35
 
 
Current Price Range
 
$4.66
 
 
Show methods +
 
 
OBIO Latest Analysis +
 
 
FAQ About OBIO Stock Insights
 

What is OBIO current stock price?

What are OBIO stock strengths?

What is OBIO Risk Level?

What is OBIO market cap and volume?

What is OBIO current Stock IQ?

Should I buy OBIO stock right now?

Is OBIO a Strong Buy right now?

What does a 'Strong Buy' rating mean for OBIO?

What does a 'Strong Sell' rating mean for OBIO?

What factors influence OBIO's Stock IQ?

 
 
StocksRunner

Explore our OBIO Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored OBIO Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our OBIO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 

OBIO

 

Orchestra BioMed Holdings

 
 

Current Price

 

$5.35

 
+$0.51 | +10.54%
 
 
52W High
$6.3
 
 
MKT CAP
$302.09M
 
52W Low
$2.2
 
 
VOL
$645.40K
 
P/E Ratio
N/A
 
 
AVG VOL
$360.53K
 
RSI
73.16
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

OBIO Rewards

 Upgraded on attractively valued

OBIO Rewards

 Trading below its fair value

 
 
 
 
user
 
 
 
 
 

OBIO Stock IQ

 
lock  Login to unlock Orchestra BioMed Holdings (OBIO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$3.79   (+41.16%)

$2.73   (+95.97%)

$2.89   (+85.12%)

$5.51   (-2.90%)

 
 
1year
6month
3month
1month
 

OBIO Analysts Opinion

 

OBIO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

OBIO Earnings Sentiment

 Above analyst estimates

OBIO Earnings Sentiment

 Loss widens YoY

 
 

Rating

×
 

Rating

 

OBIO Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

OBIO Future Sentiment

 Trading below its fair value

 
 

OBIO Analysts Opinion

OBIO Analysts opinion is positive and also has improved from the past 3 months

 

OBIO Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
92%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

OBIO Street Sentiment 

OBIO Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

OBIO Risk Level

 

OBIO has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 Price under $5

 Low volume

 High volatilty

 
 
OBIO Risk Level
Medium
LOW
HIGH
 
OBIO Performance Sentiment
 
Sentiments overview associated with OBIO events and the stock performance.
 
92%
8%
Positive
Negative
12 out of 13
events present
1 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$4.53
 
Resistance
Price
 
$2.35
 
 
Current Price Range
 
$4.66
 
 
Show methods +
 
 
 
 
 
 

OBIO Latest Analysis

 
 
 

Chardan Capital Maintains Orchestra BioMed Holdings (OBIO) Buy Recommendation. Fintel reports that on November 13 2025 Chardan Capital maintained coverage of Orchestra BioMed Holdings (NasdaqGM:OBIO) with a Buy recommendation. Analyst Price Forecast Suggests 229.43% Upside

 

Fri Nov 14, 2025

$3.93 | -6.58%
 
Rating

Barclays Maintains Orchestra BioMed Holdings (OBIO) Overweight Recommendation. Fintel reports that on November 12 2025 Barclays maintained coverage of Orchestra BioMed Holdings (NasdaqGM:OBIO) with a Overweight recommendation. Analyst Price Forecast Suggests 210.14% Upside

 

Thu Nov 13, 2025

$4.18 | -5.43%
 
Rating

Orchestra BioMed Holdings Inc. (OBIO) Reports Q3 Loss Beats Revenue Estimates. Orchestra BioMed Holdings Inc. (OBIO) delivered earnings and revenue surprises of -5.26% and 15.42% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Mon Nov 10, 2025

$3.78 | -0.79%
 
Earnings

Orchestra BioMed GAAP EPS of -$0.40 in-line revenue of $0.9M beats by $0.15M.

 

Mon Nov 10, 2025

$3.78 | -0.79%
 
Earnings

Orchestra BioMed Holdings Q3 Loss Widens . (RTTNews) - Orchestra BioMed Holdings Inc. (OBIO) Monday reported a third-quarter net loss of $20.8 million or $0.40 per share compared with a net loss of $15.4 million or $0.41 per share for the third quarter of 2024.

 

Mon Nov 10, 2025

$3.78 | -0.79%
 
Earnings

LGND: Target Up On Improved Growth Outlook. By Ligand Pharmaceuticals Inc. (NASDAQ:LGND) reported outstanding results for its third quarter with revenues almost double our estimates and adjusted core earnings per share (EPS) more than 60% greater. While contributions from the spin out of Pelthos contributed the most revenue growth in other areas was also strong. Royalties grew almost 50% and Captisol increased over 70%. Other activity since the previous quarterly update includes a $460 million c

 

Mon Nov 10, 2025

$3.78 | -0.79%
 
Activity
Potential
 
 
 
 
 
StocksRunner

Discover OBIO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of OBIO. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our OBIO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

OBIO Stock trends

OBIO Stock performance

OBIO Stock analysis

OBIO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

OBIO Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing OBIO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing OBIO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.